Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19.

The breast journal 2021 Vol.27(8) p. 671-674

Rich MD, Sorenson TJ, Schubert W

관련 도메인

Abstract

There are increasing reports of autoimmune and dermatologic sequelae of COVID-19. We describe an otherwise healthy patient with recent history of serious COVID-19 infection who developed post-surgical pyoderma gangrenosum following bilateral reduction mammoplasty and was successfully treated with infliximab, mycophenolic acid, and corticosteroids. We present this case to highlight the lingering systemic proinflammatory effects of COVID-19 infection that may increase the risk of rare autoimmune complications of surgery. As a complete understanding of the long-term effects of COVID-19 is poorly understood, patients with a history of COVID-19 infection should be appropriately counseled to these possible risks when discussing surgery.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 infection 감염 dict 3
시술 reduction mammoplasty 유방성형술 dict 1
약물 mycophenolic acid C0026933
mycophenolic acid
scispacy 1
약물 COVID-19 scispacy 1
약물 infliximab scispacy 1
약물 corticosteroids scispacy 1
질환 pyoderma gangrenosum C0085652
Pyoderma Gangrenosum
scispacy 1
질환 autoimmune and dermatologic sequelae scispacy 1
질환 COVID-19 infection C5203670
COVID19 (disease)
scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1

MeSH Terms

Breast Neoplasms; COVID-19; Female; Humans; Mammaplasty; Pyoderma Gangrenosum; SARS-CoV-2

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문